ストックスクリーナーアプリを入手
230.84
0.68%
-1.57
アフターアワーズ：
230.84
前日終値:
$232.41
開ける：
$234.89
24時間の取引高:
1.34M
Relative Volume:
1.26
時価総額：
$33.63B
収益：
$5.40B
当期純損益:
$1.49B
株価収益率:
22.82
EPS:
10.1168
ネットキャッシュフロー:
$1.78B
1週間 パフォーマンス:
-8.71%
1か月 パフォーマンス:
-8.60%
6か月 パフォーマンス:
-14.55%
1年 パフォーマンス:
+5.06%
1日の値動き範囲:
$230.21
$235.80
1週間の範囲:
$230.21
$253.13
52週間の値動き範囲:
$199.92
$293.81
Resmed Inc Stock (RMD) Company Profile
Compare RMD vs ISRG, BDX, ALC, MDLN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
230.84 | 33.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
ISRG
Intuitive Surgical Inc
|
472.16 | 167.68B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
159.36 | 45.33B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
77.32 | 37.69B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
41.46 | 33.65B | 28.43B | 1.16B | 1.26B | 1.4457 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-16 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-09-18 | 開始されました | Citigroup | Buy |
| 2025-09-02 | アップグレード | CLSA | Hold → Outperform |
| 2025-07-15 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-19 | 開始されました | Morgan Stanley | Overweight |
| 2025-01-16 | 開始されました | Goldman | Buy |
| 2025-01-10 | 開始されました | Piper Sandler | Neutral |
| 2024-12-13 | 開始されました | Stifel | Hold |
| 2024-09-24 | 開始されました | Robert W. Baird | Outperform |
| 2024-09-18 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | ダウングレード | Needham | Buy → Hold |
| 2024-06-25 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-06-24 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-02-06 | 再開されました | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-09-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | アップグレード | Needham | Hold → Buy |
| 2023-09-05 | ダウングレード | UBS | Buy → Neutral |
| 2023-08-01 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | 開始されました | UBS | Buy |
| 2023-04-14 | 開始されました | Mizuho | Buy |
| 2023-01-17 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-10-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-20 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-09-08 | アップグレード | Citigroup | Neutral → Buy |
| 2022-08-15 | ダウングレード | CLSA | Buy → Outperform |
| 2022-08-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-08-12 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-08-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-01-31 | アップグレード | Citigroup | Neutral → Buy |
| 2022-01-31 | アップグレード | Goldman | Neutral → Buy |
| 2022-01-28 | アップグレード | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-01-24 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-01-13 | アップグレード | CLSA | Outperform → Buy |
| 2022-01-13 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | アップグレード | Macquarie | Neutral → Outperform |
| 2021-10-22 | アップグレード | CLSA | Underperform → Outperform |
| 2021-08-02 | ダウングレード | CLSA | Outperform → Sell |
| 2021-08-02 | ダウングレード | Needham | Buy → Hold |
| 2021-07-28 | アップグレード | Jefferies | Underperform → Hold |
| 2021-07-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-07-14 | 開始されました | RBC Capital Mkts | Underperform |
| 2021-06-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-06-22 | アップグレード | Macquarie | Neutral → Outperform |
| 2021-06-22 | 開始されました | Robert W. Baird | Neutral |
| 2021-06-21 | 繰り返されました | Needham | Buy |
| 2021-06-16 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-06-09 | アップグレード | CLSA | Sell → Outperform |
| 2021-05-21 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-05-11 | アップグレード | Citigroup | Neutral → Buy |
| 2021-04-30 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-03-16 | アップグレード | Needham | Hold → Buy |
| 2020-11-02 | アップグレード | UBS | Neutral → Buy |
| 2020-10-30 | アップグレード | JP Morgan | Underweight → Neutral |
| 2020-10-27 | アップグレード | BofA Securities | Underperform → Neutral |
| 2020-08-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2020-05-01 | アップグレード | Oppenheimer | Perform → Outperform |
| 2020-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | 開始されました | CLSA | Underperform |
| 2020-01-31 | ダウングレード | UBS | Buy → Neutral |
| 2020-01-10 | 開始されました | Oppenheimer | Perform |
| 2019-11-22 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | アップグレード | UBS | Neutral → Buy |
| 2019-07-16 | ダウングレード | UBS | Buy → Neutral |
| 2019-05-06 | アップグレード | UBS | Neutral → Buy |
| 2019-04-18 | アップグレード | JP Morgan | Underweight → Neutral |
| 2019-01-25 | ダウングレード | Goldman | Buy → Neutral |
| 2019-01-25 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2018-10-26 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | 開始されました | Goldman | Buy |
すべてを表示
Resmed Inc (RMD) 最新ニュース
3 Reasons Not to Sleep on ResMed Stock - AOL.com
2Xideas AG Acquires 8,397 Shares of ResMed Inc. $RMD - MarketBeat
Landscape Capital Management L.L.C. Boosts Stake in ResMed Inc. $RMD - MarketBeat
Russell Investments Group Boosts Stake in ResMed - National Today
Mackenzie Financial Corp Trims Stock Position in ResMed Inc. $RMD - MarketBeat
Russell Investments Group Ltd. Has $30.85 Million Position in ResMed Inc. $RMD - MarketBeat
Bank of Montreal Can Sells 128,166 Shares of ResMed Inc. - National Today
Bank of Montreal Can Sells 128,166 Shares of ResMed Inc. $RMD - MarketBeat
ChartWatch ASX Scans: Whitehaven Coal, New Hope Corp, Yancoal, CSL, Charter Hall, Resmed, Seek, Zip Co. - Market Index
ResMed Inc. stock falls Thursday, underperforms market - MarketWatch
Legal & General Group Plc Reduces ResMed Inc. Stake - National Today
Legal & General Group Plc Reduces Stake in ResMed Inc. - National Today
Schroder Investment Management Group Boosts Stake in ResMed Inc. - National Today
Is ResMed Stock Underperforming the Nasdaq? - Barchart
Schroder Investment Management Group Boosts Stock Holdings in ResMed Inc. $RMD - MarketBeat
Legal & General Group Plc Has $262.29 Million Position in ResMed Inc. $RMD - MarketBeat
Is It Time To Reconsider ResMed (RMD) After Recent Share Price Pullback - simplywall.st
ChartWatch ASX Scans: Lynas Rare Earths, Finder Energy, Lindian Resources, Resmed, Treasury Wine Estates, Harvey Norman - Market Index
ResMed (RMD) Stock Trades Down, Here Is Why - Yahoo Finance
Hedge Fund and Insider Trading News: Bill Ackman, Stanley Druckenmiller, Ken Griffin, Caxton Associates, Braidwell LP, Rokos Capital Management, ResMed Inc (RMD), Accel Entertainment Inc (ACEL), and More - Insider Monkey
ResMed (NYSE:RMD) CEO Sells $1,252,890.73 in Stock - MarketBeat
Resmed Insider Sold Shares Worth $1,252,902, According to a Recent SEC Filing - marketscreener.com
ResMed (NYSE: RMD) CEO sells 4,991 shares after option exercise - Stock Titan
ResMed Inc. $RMD Shares Sold by Swiss National Bank - MarketBeat
Baird Adjusts Price Target on ResMed to $272 From $281, Maintains Neutral Rating - marketscreener.com
Korea Investment CORP Has $19.52 Million Stake in ResMed Inc. $RMD - MarketBeat
City of Greenwood welcomes Resmed to town - Local News Digital
3 Reasons Not to Sleep on ResMed Stock - The Motley Fool
Jefferies Financial Group Inc. Grows Position in ResMed Inc. $RMD - MarketBeat
American Century Companies Inc. Sells 94,015 Shares of ResMed Inc. $RMD - MarketBeat
Assessing ResMed (RMD) Valuation As New Greenwood Distribution Hub Targets North American Growth - Sahm
ResMed Inc. (NYSE:RMD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
ResMed (HAM:RME) Graham Number : €58.05 (As of Dec. 2025) - GuruFocus
Director sale notice: RMD (NYSE: RMD) files Form 144 to sell 4,991 shares - Stock Titan
ResMed Inc (HAM:RME) DCF Valuation - GuruFocus
ResMed (HAM:RME) 10-Year ROIIC % : 21.91% (As of Jun. 2025) - GuruFocus
ResMed (HAM:RME) Issuance of Stock : €67 Mil (TTM As of Dec. 2025) - GuruFocus
Healthcare Sector Analysis: Natera, ResMed, Globus Medical Driving InnovationNews and Statistics - IndexBox
Dundas Partners LLP Acquires 22,933 Shares of ResMed Inc. $RMD - MarketBeat
First Trust Advisors LP Buys 329,588 Shares of ResMed Inc. $RMD - MarketBeat
Neuberger Berman Group LLC Boosts Position in ResMed Inc. $RMD - MarketBeat
Blair William & Co. IL Trims ResMed Inc. Stake - National Today
Dimensional Fund Advisors LP Has $231.59 Million Stock Position in ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Sold by Blair William & Co. IL - MarketBeat
ResMed Inc. stock rises Monday, outperforms market - MSN
Crossmark Global Holdings Inc. Purchases 17,487 Shares of ResMed Inc. $RMD - MarketBeat
Marietta Investment Partners LLC Invests $2.70 Million in ResMed Inc. $RMD - MarketBeat
Resmed director Farrell sells $520k in stock - Investing.com
Insider Sell: Peter Farrell Sells 2,000 Shares of ResMed Inc (RM - GuruFocus
ResMed Director Peter Farrell Plans Modest Insider Share Sale Under Rule 144 - TipRanks
ResMed (NYSE:RMD) Director Peter Farrell Sells 2,000 Shares - MarketBeat
Resmed Inc (RMD) 財務データ
収益
当期純利益
現金流量
EPS
0.95%
1.50%
大文字化:
|
ボリューム (24 時間):